In its revised, expanded 8th edition, this book offers core knowledge of cardiovascular therapeutics. Covers beta-blockers, ACE inhibitors, and antiplatelet agents, as well as drug interactions, and use of cardiac drugs in pregnant and lactating patients.

This book is an essential guide to the medical treatment of the cardiac patient and presents core principles of cardiovascular therapeutics as well as drug recommendations. Major classes of drugs are featured, including beta-blockers, ACE inhibitors, calcium antagonists, diuretics, and antiplatelet agents and unique insights into the controversies surrounding the use of specific drugs are explored, with answers given to the question: do beta blockers and diuretics really cause diabetes? Properties, dosage, side effects, potential salutary benefits, and drawbacks on virtually all commercially available cardiac drugs are examined. This revised edition is thoroughly updated and addresses the entire spectrum of heart disorders, such as hypertension, angina, myocardial infarction, heart failure, arrhythmias, cardiac arrest, and dyslipidemias. New chapters include endocrine heart diseases, management of cardiomyopathies, and newer agents. In addition, topics such as cardiac drugs in pregnancy and lactation and drug interactions are covered. Cardiac Drug Therapy , Eighth Edition, is an authoritative and clinically relevant resource for cardiologists, cardiology fellows, and internists.

Designed to fit in a coat pocket, this book provides a quick reference to drug therapies available for every type of cardiovascular disease Fully revised, the eighth edition is expanded and contains new chapters on PCI, Cardiomyopathies, and new cardiac agents ECGs are featured to illustrate clinical cardiac findings Key chapters discuss all major drug classes and the controversies surrounding them, presenting major evidence in relation to the author's recommendations Includes supplementary material: sn.pub/extras

Autorentext
Dr. M. Gabriel Khan is a cardiologist at the Ottawa Hospital and an Associate Professor of Medicine, at the University of Ottawa. Dr. Khan graduated MB, BCh, with First-Class Honours at The Queen's University of Belfast. He obtained , by thesis, the Degree of Doctor of Medicine with Honours ( QUB). He is the author of Encyclopedia of Heart Diseases, Academic Press/ Elsevier, 2006; Encyclopedia of Heart Diseases, 2nd ed., Springer Science+Business Media, 2011; Rapid ECG Interpretation, 3rd ed., Humana Press/Springer Science+Business Media, 2008; On Call Cardiology, 3rd ed., Elsevier, 2006; Heart Disease Diagnosis and Therapy, 2nd ed., Humana Press, 2006; Cardiac and Pulmonary Management (1993); Medical Diagnosis and Therapy (1994); Heart Attacks, Hypertension and Heart Drugs (1986); and Heart Trouble Encyclopedia (1996).

Inhalt

Beta-Blockers: The Cornerstone of Cardiac Drug Therapy.- Beta-Blocker Controversies.- Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers.- ACE Inhibitor Controversies.- Calcium Antagonists (Calcium Channel Blockers).- Calcium Antagonist Controversies.- Diuretics.- Hypertension.- Hypertension Controversies.- Angina.- Acute Myocardial Infarction.- Heart Failure.- Heart Failure Controversies.- Management of Cardiac Arrhythmias.- Cardiac Arrest.- Management of Infective Endocarditis.- Dyslipidemias.- Endocrine Heart Diseases.- Antiplatelet Agents, Anticoagulants, Factor XA Inhibitors, Thrombin Inhibitors.- Cardiac Drugs During Pregnancy and Lactation.- Effects of Drug Interactions.- Hallmark Clinical Trials.- Management of Cardiomyopathies.- Newer Agents.